To provide young scholars with an active academic exchange platform for exchanging ideas with each other and influential experts in rare disease and orphan drugs, the Editorial Office of Rare Disease and Orphan Drugs Journal (RDODJ) is constructing an editorial board specifically for young editorial members.
Today, OAE formally announced the appointment of Professor Daniel Scherman, as the Editor-in-Chief of Rare Disease and Orphan Drugs Journal (RDODJ), a new online journal launched by OAE in March 2021.
Rare Disease and Orphan Drugs Journal
